Gene genius
New spinout to develop gene therapies targeting rare lung diseases
AlveoGene will work on gene therapies for several rare lung conditions, beginning with alpha-1 antitrypsin deficiency.
New spinout to develop gene therapies targeting rare lung diseases
AlveoGene will work on gene therapies for several rare lung conditions, beginning with alpha-1 antitrypsin deficiency.
How old is your heart? AI predicts “heart age” and pinpoints link to genes.
Scientists develop a new AI tool which calculates ‘Heart Age’ more accurately than ever and helps pinpoint genes for ageing.
£1.5m ‘Quest for Cures’ grant to tackle aggressive brain tumours
An Imperial team engineering new techniques in cancer immunotherapy has been awarded £1.5m over five years.
Apollo Therapeutics raises $226.5m to develop medicines based on uni research
Company founded by the tech transfer offices of Imperial, Cambridge and UCL has raised major Series C funding to turn basic research into medicines.
Research sheds light on how breast cancer might develop after pregnancy
A study observing changes in healthy breast cells may explain why breast cancer might develop after pregnancy.
Q&A: How can medical science better serve women?
Underfunding in reproductive health research, exclusion from clinical trials and misinformation mean women are being underserved by medical science.
1
Imperial Professor co-leads UK’s first womb transplant operation
After more than 25 years of research, a team co-led by Imperial’s Professor Richard Smith has performed the first womb transplant in the UK.
Study identifies vulnerable groups least likely to have COVID-19 antibodies
Findings from the MELODY study have identified which people with compromised immune systems are less likely to have COVID-19 antibodies.
Government funding to ‘revolutionise AI healthcare research'
UKRI announces £13 million funding for artificial intelligence in health, with three projects launched at Imperial College London.
New research using ‘smart’ socks could transform dementia care
A sock which combines sensors with artificial intelligence could help care staff detect agitation and prevent falls in people with dementia.